StreetInsider.com News Articles

Form 8-K TELEFLEX INC For: Jun 01

Tue, 02 Jun 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260602/26586632.html

Form 8-K TELEFLEX INC For: Jun 01

Tue, 02 Jun 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260602/26586632.html

Teleflex prices $500 million senior notes offering at 5.875%

Mon, 01 Jun 2026 17:40:12 -0400

Teleflex Incorporated (NYSE: TFX) announced it priced a private offering of $500 million in senior notes due 2032 at a 5.875% interest rate and an issue price of 100.000%.

The Wayne, Pennsylvania-based medical technology company expects the sale to close on June 15, 2026, subject to customary closing conditions. The notes will be guaranteed by Teleflex's existing and future wholly-owned domestic subsidiaries that serve as guarantors under its credit agreement.

Teleflex plans to use the net proceeds from the offering, along with cash on hand, to redeem all outstanding 4.625% Senior Notes due 2027.

The offering will be conducted as a private transaction

Teleflex prices $500 million senior notes offering at 5.875%

Mon, 01 Jun 2026 17:40:12 -0400

Teleflex Incorporated (NYSE: TFX) announced it priced a private offering of $500 million in senior notes due 2032 at a 5.875% interest rate and an issue price of 100.000%.

Teleflex plans to use the net proceeds from the offering, along with cash on hand, to redeem all outstanding 4.625% Senior Notes due 2027.

The offering will be conducted as a private transaction

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

Mon, 01 Jun 2026 17:40:00 -0400

WAYNE, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today that it priced its private offering of $500.0 million aggregate principal amount of 5.875% senior notes due 2032 (the “Notes”) at an issue price of 100.000%. The sale of the Notes is expected to close on June 15, 2026, subject to customary closing conditions.

The Notes will be guaranteed by each of Teleflex’s existing and future wholly-owned domestic subsidiaries that is a guarantor or other obligor under its credit agreement and certain other indebtedness.

Teleflex intends to use the net proceeds from the offering, together with cash on hand,

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

Mon, 01 Jun 2026 17:40:00 -0400

Teleflex intends to use the net proceeds from the offering, together with cash on hand,

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

Mon, 01 Jun 2026 17:40:00 -0400

Teleflex intends to use the net proceeds from the offering, together with cash on hand,

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

Mon, 01 Jun 2026 17:40:00 -0400

Teleflex intends to use the net proceeds from the offering, together with cash on hand,

Form 8-K TELEFLEX INC For: Jun 01

Mon, 01 Jun 2026 08:01:00 -0400

si-local-file:///var/storage/secattach/20260601/26579585.html

Form 8-K TELEFLEX INC For: Jun 01

Mon, 01 Jun 2026 08:01:00 -0400

si-local-file:///var/storage/secattach/20260601/26579585.html

Teleflex launches $500 million senior notes offering due 2032

Mon, 01 Jun 2026 07:45:25 -0400

Teleflex Incorporated (NYSE: TFX) announced the commencement of a private offering of $500 million in senior notes due 2032, according to a company statement.

The medical technology company said the interest rate and other terms of the notes will be determined at pricing, subject to market and other conditions. The notes will be guaranteed by Teleflex's existing and future wholly-owned domestic subsidiaries that serve as guarantors under its credit agreement.

Teleflex plans to use the net proceeds from the offering, combined with cash on hand, to redeem all outstanding 4.625% Senior Notes due 2027.

The offering will be conducted as a private transaction

Teleflex launches $500 million senior notes offering due 2032

Mon, 01 Jun 2026 07:45:25 -0400

Teleflex Incorporated (NYSE: TFX) announced the commencement of a private offering of $500 million in senior notes due 2032, according to a company statement.

Teleflex plans to use the net proceeds from the offering, combined with cash on hand, to redeem all outstanding 4.625% Senior Notes due 2027.

The offering will be conducted as a private transaction

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

Mon, 01 Jun 2026 07:45:00 -0400

WAYNE, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today the commencement of a private offering of $500.0 million aggregate principal amount of senior notes due 2032 (the “Notes”), subject to market and other conditions. The interest rate and other terms of the Notes will be determined at pricing.

Teleflex intends to use the net proceeds from the offering, together with cash on hand, to redeem all of its

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

Mon, 01 Jun 2026 07:45:00 -0400

Teleflex intends to use the net proceeds from the offering, together with cash on hand, to redeem all of its

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

Mon, 01 Jun 2026 07:45:00 -0400

Teleflex intends to use the net proceeds from the offering, together with cash on hand, to redeem all of its

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

Mon, 01 Jun 2026 07:45:00 -0400

Teleflex intends to use the net proceeds from the offering, together with cash on hand, to redeem all of its

Form SD TELEFLEX INC

Thu, 28 May 2026 14:22:00 -0400

si-local-file:///var/storage/secattach/20260528/26565458.html

Form SD TELEFLEX INC

Thu, 28 May 2026 14:22:00 -0400

si-local-file:///var/storage/secattach/20260528/26565458.html

Form 8-K TELEFLEX INC For: May 26

Wed, 27 May 2026 17:23:00 -0400

si-local-file:///var/storage/secattach/20260527/26559189.html

Form 8-K TELEFLEX INC For: May 26

Wed, 27 May 2026 17:23:00 -0400

si-local-file:///var/storage/secattach/20260527/26559189.html

Teleflex presents clinical data showing UroLift system benefits

Thu, 21 May 2026 06:30:46 -0400

Teleflex Incorporated (NYSE: TFX) presented clinical data at urological conferences showing patient experience advantages for its UroLift System and long-term toxicity reduction with its Barrigel rectal spacer, according to a company statement.

The data was presented at the American Urological Association Annual Meeting and European Society for Radiotherapy & Oncology Congress in May 2026.

The CLEAR randomized controlled trial, the first head-to-head comparison of minimally invasive surgical therapies for benign prostatic hyperplasia, showed catheter independence from day three through seven was significantly better among UroLift System patients compared to Rezūm patients, with 3 percent requiring catheter versus 20 percent respectively. The study

Teleflex presents clinical data showing UroLift system benefits

Thu, 21 May 2026 06:30:46 -0400

The data was presented at the American Urological Association Annual Meeting and European Society for Radiotherapy & Oncology Congress in May 2026.

Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Space

Thu, 21 May 2026 06:30:00 -0400

First Head-to-Head Randomized Control Study (RCT) Reinforces Early Patient Experience Benefits and 12-month Durability of the UroLift™ System versus Rezūm™1

Three-Year Data Demonstrate Sustained Reduction in Gastrointestinal Toxicity with Barrigel™ Rectal Spacer2

WAYNE, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the Interventional Urology Business Unit has released new clinical data across two major urological congresses, reinforcing the value of the UroLift™ System and Barrigel™ rectal spacer in improving patient-centered outcomes across benign prostatic hyperplasia (BPH) and prostate cancer care. Teleflex Interventional Urology innovations help urologists treat medical needs while

Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Space

Thu, 21 May 2026 06:30:00 -0400

First Head-to-Head Randomized Control Study (RCT) Reinforces Early Patient Experience Benefits and 12-month Durability of the UroLift™ System versus Rezūm™1

Three-Year Data Demonstrate Sustained Reduction in Gastrointestinal Toxicity with Barrigel™ Rectal Spacer2

Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Space

Thu, 21 May 2026 06:30:00 -0400

First Head-to-Head Randomized Control Study (RCT) Reinforces Early Patient Experience Benefits and 12-month Durability of the UroLift™ System versus Rezūm™1

Three-Year Data Demonstrate Sustained Reduction in Gastrointestinal Toxicity with Barrigel™ Rectal Spacer2